Catalyst Wire Dossier Catalyst Wire Dossier

MIND1

· Otsuka Pharmaceutical Development & Commercialization, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MIND1, covering 2015-04-28 to 2018-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole [Phase 2]

See pricing